Ondine Biomedical Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

ondinebio.com

Country

Canada

Exchange

LSE

Vancouver, Canada

Ondine Biomedical Inc., a life-sciences company develops activated antimicrobial therapies for the prevention and treatment of infections in Canada and globally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose, as well as a pipeline of photodisinfection products for various indications Including chronic sinusitis, ventilator-associated pneumonia, burns and indications. Incorporated in 1996, Ondine Biomedical is headquartered in Vancouver, Canada.

Key Stats

52-Week Range

£0.00£18.50

Beta0.32

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.03

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.